Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3256641 | 0.86 | KMT2A (0.32) | TSHRL3MBTL1ALDH1A1 | |
| SCHEMBL743722 | 0.85 | HSD11B1 (0.38) | TSHRCYP1A2HSD11B1L3MBTL1ALDH1A1 | |
| SCHEMBL3254927 | 0.83 | FFAR3 (0.32) | TSHRCYP1A2FFAR3HSD11B1L3MBTL1 | |
| SCHEMBL720430 | 0.80 | KDM4E (0.33) | — | |
| SCHEMBL22292115 | 0.79 | HSD11B1 (0.34) | TSHRCYP1A2HSD11B1ALDH1A1BLM | |
| SCHEMBL16946084 | 0.78 | TSHR (0.31) | TSHRALDH1A1 | |
| SCHEMBL13124944 | 0.78 | AKR1B1 (0.39) | TSHRALDH1A1ALOX15SLC22A6 | |
| SCHEMBL12254218 | 0.77 | TSHR (0.42) | TSHRCYP1A2HSD11B1ALDH1A1BLM | |
| SCHEMBL7272014 | 0.77 | TSHR (0.33) | TSHRHSD11B1ALDH1A1CYP2C19 | |
| SCHEMBL16946087 | 0.77 | HTT (0.32) | TSHRCYP1A2HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3389733-A1 | COMPOSITIONS, DELIVERY SYSTEMS AND REFILLS FOR EMITTING TWO OR MORE COMPOSITIONS | S.C. Johnson & Son, Inc. (US) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017105725-A1 | COMPOSITIONS, DELIVERY SYSTEMS AND REFILLS FOR EMITTING TWO OR MORE COMPOSITIONS | S. C. JOHNSON & SON, INC. (US) | 2017-06-22 | — | — | WO | disclosed |
| US-9371275-B2 | 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis | SWEDISH PHARMA AB (SE) | 2016-06-21 | — | — | US | disclosed |
| EP-1870409-B1 | BENZIMIDAZOLE COMPOUNDS | EISAI R&D MAN CO LTD (JP) | 2010-05-12 | — | — | EP | disclosed |
| US-20090203911-A1 | BENZIMIDAZOLE COMPOUND | MIYAZAWA SHUHEI | 2009-08-13 | — | — | US | disclosed |
| EP-1870409-A1 | BENZIMIDAZOLE COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2007-12-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203911-A1 | BENZIMIDAZOLE COMPOUND | HRH2, HRH4, HRH1 | TSHR 791/4885CYP1A2 3448/4885FFAR3 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.